Essentials
• The self-inhibitory mechanism of von Willebrand factor (VWF) remains unclear.
• Residues flanking the A1 domain of VWF form a discontinuous autoinhibitory module (AIM).
• rVWF 1238-1493 exhibited greater thermostability and inactivity than its shorter counterparts.
• The cooperative coupling between the N-and C-AIM regions are required for inhibiting A1.
Summary. Background:
The hierarchical hemostasis response involves a self-inhibitory feature of von Willebrand factor (VWF) that has not been fully characterized. The residues flanking the A1 domain of VWF are important in this self-inhibition by forming an autoinhibitory module (AIM) that masks the A1 domain. Objectives: To delimit the AIM sequence and to evaluate the cooperative interplay between the discontinuous AIM regions. Methods: ELISA, flow cytometry, a thermal stability assay and hydrogen-deuterium exchange (HDX) mass spectrometry were used to characterize recombinant VWF A1 fragments varying in length. Results: The longest A1 fragment (rVWF ) showed higher inactivity in binding the platelet receptor glycoprotein (GP) Iba and greater thermostability than its shorter counterparts. The HDX results showed that most of the N-terminal residues and residues 1459-1478 at the C-terminus of rVWF have slower deuterium uptake than the residues in its denatured counterpart, implying that these residues may interact with the A1 domain. In contrast, residues 1479-1493 showed less difference from the denatured form, indicating that these residues are unlikely to be involved in binding the A1 domain. The A1 fragment that lacks either the entire C-terminal flanking region of the AIM (C-AIM), i.e. rVWF , or the entire N-terminal flanking region of the AIM (N-AIM), i.e. rVWF , showed high GPIba-binding affinity and low thermostability, suggesting that removal of either N-terminal or Cterminal residues resulted in loss of AIM inhibition of the A1 domain. Conclusion: The AIM is probably composed of residues 1238-1271 (N-AIM) and 1459-1478 (C-AIM).
Introduction
von Willebrand factor (VWF) is a large blood glycoprotein (GP) that is essential for normal hemostasis. Most plasma VWF molecules are secreted in a multimeric form by endothelial cells. These VWF molecules often adopt a loosely condensed 'ball-of-yarn' shape under low shear conditions, and remain hemostatically inactive [1] . Activation of VWF in vivo normally requires high-shear conditions, where tension resulting from flow straightens VWF molecules in the direction of flow and subsequently exposes the platelet-binding domain in VWF -the A1 domain (residues 1272-1458). Binding of the VWF A1 domain to the platelet receptor GPIba triggers the downstream signaling pathway of platelets and leads to their activation. Deficiency or malfunction of VWF is a common cause of bleeding or thrombosis [2] .
How VWF retains its hemostatic inactivity under lowshear conditions remains ambiguous. Manifestly, the ballof-yarn shape of VWF may shadow the A1 domain and therefore block GPIba binding. However, studies on isolated or recombinant A1 fragments have shown that those A1 fragments containing residues flanking the A1 domain are as inactive as full-length VWF under low-shear conditions [3] [4] [5] [6] [7] . However, those A1 fragments containing fewer flanking residues have high hemostatic activity in the absence of shear or agonist treatment [8, 9] . In addition, a recent study showed that elongation of VWF is not sufficient to promote the binding of GPIba when the tension force is below a certain threshold [10] . Obviously, these observations argue against the VWFshadowing model, but instead raise the hypothesis that the self-inhibition of VWF is regulated by local interactions between the A1 domain and its flanking regions. The flanking regions at the N-terminus and C-terminus of the A1 domain are held together by an intramolecular disulfide bond between Cys1272 and Cys1458, like two ribbons held in one hand (Fig. 1A) . This organization gives a spatial advantage for these flanking residues to act in a cooperative manner and hypothetically bind the A1 domain and block the binding of GPIba. However, the A1 crystal structures available to date have not addressed this hypothesis, partially because the flanking residues are not included or resolved in these studies.
We recently tested the aforementioned hypothesis by using hydrogen-deuterium exchange (HDX) mass spectrometry, which is a powerful tool for probing a protein's structure in solution at high resolution [11, 12] . We characterized two recombinant A1 fragments, i.e. rVWF and rVWF , varying in the length of flanking residue sequences and showing different binding affinities for GPIba [3, 8] . HDX results suggested that the residues flanking the A1 domain in rVWF 1238-1472 (i.e., residues 1238-1271 and residues 1459-1472) bound the A1 domain cooperatively, forming a discontinuous autoinhibitory module (AIM) [9] . The binding of AIM residues to the A1 domain provided a mechanism for the different GPIba-binding activities between rVWF 1261-1472 and rVWF . However, as rVWF 1238-1472 contains only a portion of the C-terminal flanking region, the full spectrum of the AIM remained unclear. In addition, the cooperation of the discontinuous regions of AIM binding to the A1 domain was not directly verified. To delimit the AIM sequence and to evaluate the cooperative interaction between the discontinuous AIM regions, we characterized rVWF 1238-1493 , rVWF 1238-1461 and rVWF in this study. rVWF contains the full-range flanking regions, whereas rVWF 1238-1461 and rVWF 1271-1493 contain either the entire N-terminus or the entire C-terminus, respectively, but lack the other halves of the flanking regions. Our results indicate that the range of the AIM probably stops at Gly1479, and that the cooperative interactions of the two discontinuous flanking regions of the AIM are required to protect the A1 domain.
Materials and methods
Plasma-derived VWF was purchased from Haematological Technologies (Essex Junction, VT, USA). Ristocetin was purchased from MP Biomedicals (Santa Ana, CA, USA). Recombinant GPIb-IX complex was purified in the laboratory as previously described [13] . SYPRO Orange dye was purchased from Thermo Fisher Scientific (Waltham, MA, USA). Ammonium sulfate (protease-free) was purchased from Fisher Scientific (Merelbeke, Belgium). A 5-mL HisTrap Excel column, a Superdex 200 10/300 GL SEC column and a HiLoad Superdex 200-pg 1660 size exclusion column were purchased from GE Healthcare Life Science (Pittsburgh, PA, USA).
Protein purification
Expression and purification of rVWF 1261-1472 , rVWF , rVWF 1238-1461 and rVWF were performed with the same protocol as previously described [9] . rVWF was purified with a two-step purification protocol. The cell culture medium containing rVWF was centrifuged at 5000 9 g for 30 min at 4°C and sterile-filtered. Ammonium sulfate powder was added slowly with stirring, and a protein pellet obtained between ammonium sulfate concentrations of 50% and 70% was collected and dialyzed overnight in 1 9 phosphate-buffered saline (PBS), pH 7.4. The dialyzed sample was loaded onto a pre-equilibrated 5-mL HisTrap Excel column (150 mM NaCl, 20 mM phosphate buffer, pH 7.4) at 1 mL min
À1
. The column was washed (150 mM NaCl, 20 mM phosphate buffer, 20 mM imidazole, pH 7.4) until the UV 280 was lower than 0.010 and protein was eluted (150 mM NaCl, 20 mM phosphate buffer, 500 mM imidazole, pH 7.4). The eluate was concentrated in a Vivaspin20 (molecular weight cutoff [MWCO] of 10 000 Da; Sartorius Corp., Goettingen, Germany) and loaded onto a HiLoad Superdex 200-pg 1660 size exclusion column. Fractions containing the pure protein were pooled, dialyzed overnight in 1 9 PBS, and concentrated in a Vivaspin20 (MWCO of 10 000 Da). The concentration was determined with an extinction coefficient of 0.585.
ELISA, analytical ultracentrifugation and HDX mass spectrometry were performed as described previously [9] .
Flow cytometry measurement
The informed consent and related protocols were approved by Emory University institutional review boards. Citrated whole blood, from which platelet-rich plasma (PRP) was prepared, was obtained from healthy volunteers. Platelet counts were obtained with a Sysmex XP-300 analyzer (Sysmex, Lincolnshire, IL, USA). To measure platelet binding, PRP was incubated with defined concentrations of proteins for 10 min at room temperature. After washing, the samples were mixed with 1 lg mL À1 allophycocyanin-labeled anti-His-tag mAb, fixed with 4% paraformaldehyde solution, and analyzed on a CytoFLEX S flow cytometer (Beckman, Boulevard Brea, CA, USA). The signal from the entire platelet population (10 000 platelets) was analyzed with FLOWJO (FlowJo LLC, Ashland, OR, USA). A paired t-test was conducted using GraphPad Prism 5 (GraphPad Software, Inc. CA the USA) and the P-value was marked. AIM, autoinhibitory module; a.u., arbitrary unit; C-AIM, C-terminal flanking region of the autoinhibitory module; MW, molecular weight; N-AIM, N-terminal flanking region of the autoinhibitory module; NR, non-reducing; R; Risto, ristocetin; VWF, von Willebrand factor.
Melting temperature (T m ) measurement
The T m was measured with a thermofluor assay performed on a real-time PCR instrument. The proteins were incubated in a 96-well PCR plate with SYPRO Orange dye, which undergoes a significant increase in quantum yield upon binding to hydrophobic elements exposed during protein denaturation. Four replicates from each protein were performed, and the thermal denaturation curves (reflected as the change in fluorescence intensity) of these replicates were fitted as described previously [14] . The final T m value reflects the average of these measurements, and the experimental error (standard deviation) is given.
Results
Autoinhibitory activity and thermal stability of rVWF The migration speeds of rVWF 1238-1493 on SDS-PAGE gel under non-reducing and reducing conditions were relatively close to each other, similarly to those of rVWF 1238-1472 and rVWF (Fig. 1B) . In solution, rVWF 1238-1493 remained primarily as a monomer, as shown by the size exclusion chromatography and analytical ultracentrifugation analyses (Fig. 1C,D) . We compared the binding of rVWF , rVWF 1238-1472 , rVWF 1261-1472 and plasmaderived VWF to an immobilized GPIb-IX complex by using ELISA. In the absence of agonist, rVWF 1261-1472 tightly bound GPIb-IX, rVWF 1238-1472 modestly bound GPIb-IX, whereas rVWF 1238-1493 and plasma-derived VWF did not bind GPIb-IX up to 1.2 lM (Fig. 1E) . The binding results were further examined by comparing the binding of these recombinant proteins to platelets in PRP (500 9 10 3 lL À1 platelets) at 200 nM by the use of flow cytometry. The results from flow cytometry were consistent with the ELISA data (Fig. 1F) . Similar results were obtained with washed platelets in mTyrode's buffer (134 mM NaCl, 0.34 mM Na 2 HPO 4 , 2.9 mM KCl, 1 mM MgCl 2 , 5 mM glucose, 12 mM NaHCO 3 , 20 mM HEPES, pH 7.35) (data not shown). In addition, adding ristocetin, which is an agonist that induces GPIba-VWF interaction, resulted in stimulation of the binding of plasma-derived VWF, rVWF 1238-1493 and rVWF 1238-1472 to GPIb-IX (Fig. 1G) . All of these constructs contain the A1 domain with the same conformation that is locked by the intramolecular disulfide bond [7, 8, [15] [16] [17] [18] [19] [20] . The difference between these constructs is the number of AIM residues flanking the A1 domain. Therefore, we hypothesize that the decrease in GPIba-binding activity of these constructs in the absence of agonist is attributable to the increase in the binding of AIM residues to the A1 domain. This binding probably affects the accessibility of the GPIba-binding site on the A1 domain, but should entail minimal changes in the A1 domain structure. As the binding of the AIM residues would increase the thermostability of the A1 domain, we then tested this hypothesis by measuring the thermostability of these samples. We measured the T m of these samples by using a thermofluor assay. Because the conformations of the A1 domain in these constructs are the same, the T m can be used to compare the thermal stabilities of these constructs. During the thermal denaturation, the exposure of the hydrophobic elements in the A1 domain was probed by the change of the quantum yield of a fluorophore. The T m values were 59.35 AE 0.71°C for rVWF 1238-1493 , 56.13 AE 0.90°C for rVWF 1238-1472 , and 52.06 AE 0.96°C for rVWF (Fig. 1H,I ). rVWF had the lowest T m , suggesting that it has the least coupling effect from the AIM residues. rVWF 1238-1493 had a higher T m than rVWF 1238-1472 , implying that it has a higher coupling effect than rVWF 1238-1472 . As rVWF 1238-1493 has 22 more C-terminal flanking residues than rVWF 1238-1472 , the increased thermostability of rVWF 1238-1493 may be attributable to the coupling of these extra flanking residues to the A1 domain. These results are consistent with our hypothesis that the coupling of AIM residues increases the thermostability and decreases the binding activity of A1.
Many peripheral regions in rVWF 1238-1493 are protected from HDX
To further verify the coupling of the flanking residues to the A1 domain and delimit the range of the AIM in rVWF 1238-1493 , we conducted a similar HDX analysis of rVWF 1238-1493 as performed previously with rVWF 1238-1472 and rVWF 1261-1472 [9] . With this approach, the deuterium exchange of the backbone proton on the amino acid chain of rVWF 1238-1493 was evaluated as a function of time by the use of a tandem mass spectrometer that can sequence the peptide fragments. The coupling of the flanking residues to the A1 domain would reduce the solvent accessibility of the affected backbone protons, and thus decrease their deuterium exchange rate. Two hundred and seventeen peptide fragments were identified and confirmed by tandem mass spectrometry, covering~97% of the protein sequence with a redundancy of > 10. No peptide fragment was identified covering the contiguous O-glycosylation sites T1255/ T1266 and S1486/T1487, which was probably attributable to the known limitations of mass spectrometry in identifying glycopeptides. The deuterium uptake over time of each fragment in both native and denatured proteins was overlaid on the primary protein sequence to generate a heat map ( Fig. 2A) . Consistent with our expectation, all of the N-terminal flanking residues and residues 1459-1478 in the C-terminal flanking region in rVWF 1238-1493 showed reduced HDX as compared with their denatured counterparts ( Fig. 2A) , suggesting that these residues are coupled with the A1 domain. In comparison, residues after Gly1479 showed less difference in HDX relative to their denatured counterparts, implying that these residues may not bind the A1 domain. Relative fractional deuterium uptake was plotted using the rainbow color scale. Secondary structures of each region were labeled on top. Denaturation of rVWF1238-1493 (rVWF1238-1493 + GdnHCl) was performed as described [9] . Three representative peptides around Gly1479 were selected to show their raw mass spectra and deuterium uptake in the native (red) and denatured (blue) forms. (B) 3D projection of HDX data at the indicated exchange time. HDX data were mapped to the structure of the A1 domain (Protein Data Bank, 1SQ0, only residues 1269-1466 were shown in the structure) using PyMOL. (C) 3D projection of the difference in relative fractional uptake at 10 000 s of exchange between rVWF1238-1493 and rVWF1238-1472, as defined by the color code in the figure. GdnHCl, guanidinium chloride; GP, glycoprotein; VWF, von Willebrand factor.
showed low deuterium uptake in native rVWF 1238-1493 but high uptake in the denatured form. This difference in deuterium uptake between native and denatured forms became smaller in peptide 1478-1484, and disappeared in peptide 1488-1493 (+59His) (Fig. 2A) . These results indicated that the AIM is probably composed of residues 1238-1271 (Nterminal flanking region [N-AIM]) and 1459-1478 (C-terminal flanking region [C-AIM]). Consistently, the flanking residues 1243-1271 and 1459-1481 were found to resist protease digestion in earlier studies [5, 21] . This resistance can be well explained by the binding of these residues to the A1 domain.
To determine how the binding of AIM residues to the A1 domain affects the GPIba-binding activity of these constructs, we aligned the heat maps of rVWF 1261-1472 , rVWF 1238-1472 and rVWF and projected them onto a three-dimensional structure of the A1 domain (Protein Data Bank: 1sq0) (Fig. 2B) . As indicated, many peripheral regions in rVWF 1261-1472 showed considerable deuterium exchange as early as 10 s. In contrast, the same peripheral regions in rVWF 1238-1472 and rVWF 1238-1493 were mainly not exchanged at 10 s. With the extension of exchange time, these peripheral regions in rVWF were slowly exchanged by deuterium, but many of these peripheral regions in rVWF 1238-1493 were not exchanged even at the longest labeling time point (10 000 s). These results indicate differences in solvent accessibility and dynamic flexibility of the peripheral regions in the A1 domain among these constructs. To further identify the coupling sites of AIM on the A1 domain in rVWF 1238-1493 , we compared HDX between rVWF 1238-1493 and rVWF , and projected the difference onto an A1-GPIba complex structure (Fig. 2C) . rVWF 1261-1472 has the least AIM residues and showed no coupling effect. As indicated, the peripheral regions near the GPIba-binding sites, such as a1, a2, loop b3a2, b3, and loop a3b4, were highlighted in this comparison, indicating that the AIM residues might bind at this area, impairing binding of the A1 domain to GPIba. The complete time-dependent deuterium uptake data for every peptide in each presented recombinant A1 fragment are also included in Data S1.
The N-terminal and C-terminal AIM residues mask the A1 domain in a cooperative manner Although the cooperative interplay between the N-terminal and C-terminal residues of AIM has been suggested in our previous study, generating the A1 fragments that contain only one side of the AIM would be a direct way to verify this cooperation. We generated rVWF 1238-1461 and rVWF , which are two A1 fragments missing either the entire C-terminal or entire N-terminal flanking region, respectively (Fig. 3A) . Being limited by the available material, we did not perform the Analytical Ultracentrifugation analysis on these proteins, but we think that they are primarily in the monomeric form on the basis of their elution time in gel filtration purification (Fig. S1) . The migration speeds on SDS-PAGE gels of rVWF 1238-1461 and rVWF 1271-1493 are similar (Fig. 3B) , consistent with their similarity in molecular weight. Both rVWF 1238-1461 and rVWF showed tight binding to the immobilized GPIb-IX complex, similarly to rVWF (Fig. 3C) . The binding of these proteins to platelets was examined in a similar way as shown in Fig. 1 , except that the protein concentration was 60 nM, which is the physiological concentration of VWF. The results indicated that, at 60 nM, rVWF 1238-1461 and rVWF 1271-1493 tightly associate with platelets in PRP, and, in this respect, are indistinguishable from rVWF (Fig. 3D) . Similar results were obtained with washed platelets in mTyrode's buffer (data not shown). The T m values of rVWF 1238-1461 and rVWF 1271-1493 were 50.91 AE 0.98°C and 50.91 AE 1.10°C, both of which are similar to the T m of rVWF (Fig. 3E) . These results are in strong support of the cooperation between the N-terminal and C-terminal AIM masking the A1 domain of VWF. Without the C-terminal AIM residues, the N-terminal AIM alone is not sufficient to protect the A1 domain.
Discussion
It has long been thought that the tension-regulated VWF binding to GPIba occurs through the elongation of the VWF from the 'ball-of-yarn' shape. In the current study, we demonstrate that the hemostatic activity of VWF is probably regulated by the residues flanking the A1 domain. The great consistency of the results from binding, thermostability and HDX assessments in our study indicates that the coupling of AIM residues to the A1 domain is critical for the GPIba-binding activity of VWF. More importantly, our results suggest that the coupling between the flanking residues and the A1 domain might be a multivalent interaction, whereas the flanking residues dynamically interact with multiple binding sites on the looped A1 domain. Shortening the AIM residues from rVWF 1238-1493 to rVWF increased the GPIba-binding activity but did not result in full activatation of the A1 domain. Additionally, rVWF contained more HDX-protected regions than rVWF 1238-1472 . These observations suggest multivalent binding between the AIM and the A1 domain. As reported recently, GPIba binding to VWF shows a sigmoidal dependence on tensile force [10] . The exponential phase of the sigmoidal curve, in which the binding of GPIba gradually increased, covered a wide force range from 10 pN to 40 pN. This observation can be well explained by the potentially stepwise uncoupling of the multivalent interaction between the AIM and the A1 domain.
The binding sites of these AIM residues are largely overlaid by the GPIba-binding sites in the A1 domain. One should also note that, owing to the increased global stability of the A1 domain resulting from the coupling of AIM residues, some regions that are not in direct contact with the AIM could also show slower HDX, because of an allosteric effect. It is not possible to distinguish the coupling effect from the allosteric effect, because both of them substantially contributed to slow HDX in this case [22] . In full-length VWF, the potential interactions between the A1 domain and other domains such as the D domains or other A domains may also affect the GPIbabinding activity of VWF [23] [24] [25] [26] . These interactions may indeed exist, but they should not contribute significantly to inhibition of the A1 domain, for two reasons. First, rVWF showed the same inactivity as full-length VWF, suggesting that it contains sufficient inhibitory elements as compared with the full-length protein. Second, in a low-tension force environment, GPIba does not bind to VWF even when it is elongated, suggesting that domain-domain interactions play a minor role in inhibiting the A1 domain [10] . However, it is possible that these domain-domain interactions in VWF may affect the binding of the AIM to the A1 domain, and may therefore influence the GPIba-binding activity of VWF.
Thermostability measurements have been applied to study the folding/unfolding of different domains in VWF [27] [28] [29] [30] , but they are rarely used to study the interaction between the VWF A1 domain and its ligands. According to our findings, the T m of the A1 domain is % 51°C when it is deprotected. With the coupling of AIM, the T m of the A1 domain could reach 60°C. It is technically challenging to test the thermostability of the A1 domain in the full-length VWF monomer. However, it is reasonable to expect that, in type 2b von Willebrand disease mutants or in ultralarge multimers, where VWF is associated with hyperactivity, the thermostability of the A1 domain is lower than that in wild-type VWF, owing to unmasking of the A1 domain.
We verified in the current study that the cooperative binding between the N-AIM and C-AIM is required for inhibition of the A1 domain. Predictably, unzipping the AIM by mutating residues on either side of the AIM dampened the autoinhibition of VWF. Both the N-AIM and the C-AIM appear to simultaneously bind to ristocetin, as suggested by multiple studies [31] [32] [33] [34] [35] . Apparently, this is only possible when the N-AIM and the C-AIM are cooperatively bound to the A1 domain. Interestingly, rVWF 1238-1493 showed higher sensitivity to ristocetin-mediated GPIba binding than rVWF (Fig. 1F) , suggesting that the residues beyond position 1472 in the C-AIM may participate in binding ristocetin. However, a more rigorous characterization is required to determine how ristocetin interacts with VWF.
We did not have evidence for the mechanosensory behavior of the AIM in the current study, but, on the basis of its essential contribution to the activity of the VWF A1 domain, we think that the AIM is probably in the center of the mechanosensing regulatory mechanism of VWF. For VWF activation, unzipping of the AIM could be the determinant local transition to the state with high affinity for platelets. The elongation of VWF from a compact to a linear form, instead, occurs prior to its activation, as shown in a recent study [10] . It is becoming increasingly clear that the activation of VWF is determined by local elements rather than global domain-domain interactions [9, 10] . Perhaps the AIM is intrinsically disordered, and the local environment of VWF multimers dynamically regulates the multivalent binding of the AIM to the A1 domain, which enables a unique shear-dependent regulatory mechanism. The exact force to unzip the AIM and the structure of the AIM are subjects for future studies.
In summary, the delimitation of the residues in the AIM of VWF in the current study solidifies the hypothesis that residues flanking the A1 domain of VWF regulate the hemostatic activity of VWF by directly masking the A1 domain. Uncoupling of the likely multivalent interactions of the AIM with the A1 domain might be a general mechanism for VWF to act as a mechanosensor to enable different responses to different shear environments in the blood circulation. 
